| 摘要 |
<p>Selective inhibitors of the cPLA2 enzymes are provided which are of use in controlling a wide variety of inflammatory diseases. The inhibitors of the present invention have general formula (i), where (R1), p, D, Y, Z, Ra, Rb and A are as defined in the specification.</p> |
